OMKAR PHARMACHEM [OMKARPH] vs Divi's Laboratories [DIVISLAB] Detailed Stock Comparison

OMKAR PHARMACHEM LTD.

BSE
Loading...

Divi's Laboratories Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: OMKAR PHARMACHEM LTD. wins in 4 metrics, Divi's Laboratories Ltd. wins in 13 metrics, with 1 ties. Divi's Laboratories Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric OMKAR PHARMACHEM LTD. Divi's Laboratories Ltd. Better
P/E Ratio (TTM) 327.78 67.11 Divi's Laboratories Ltd.
Price-to-Book Ratio 3.13 10.82 OMKAR PHARMACHEM LTD.
Debt-to-Equity Ratio 0.00 0.58 Tie
PEG Ratio -5.03 4.63 Divi's Laboratories Ltd.
EV/EBITDA 140.88 48.63 Divi's Laboratories Ltd.
Profit Margin (TTM) 16.73% 24.04% Divi's Laboratories Ltd.
Operating Margin (TTM) 37.71% 29.65% OMKAR PHARMACHEM LTD.
EBITDA Margin (TTM) 37.71% 29.65% OMKAR PHARMACHEM LTD.
Return on Equity 2.13% 14.64% Divi's Laboratories Ltd.
Return on Assets (TTM) 2.09% 12.94% Divi's Laboratories Ltd.
Free Cash Flow (TTM) $2.40M $2.15B Divi's Laboratories Ltd.
Dividend Yield N/A 0.91% N/A
1-Year Return -3.09% 0.83% Divi's Laboratories Ltd.
Price-to-Sales Ratio (TTM) 58.34 16.18 Divi's Laboratories Ltd.
Enterprise Value $296.42M $1,635.46B Divi's Laboratories Ltd.
EV/Revenue Ratio 58.12 15.86 Divi's Laboratories Ltd.
Gross Profit Margin (TTM) N/A 63.71% N/A
Revenue per Share (TTM) $1 $388 Divi's Laboratories Ltd.
Earnings per Share (Diluted) $0.09 $93.66 Divi's Laboratories Ltd.
Beta (Stock Volatility) 0.10 0.19 OMKAR PHARMACHEM LTD.

OMKAR PHARMACHEM LTD. vs Divi's Laboratories Ltd. Stock Performance Analysis

Loading Price Chart...

OMKARPH
DIVISLAB

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
OMKAR PHARMACHEM LTD.-4.99%-5.00%-8.49%-13.05%-9.46%-13.75%
Divi's Laboratories Ltd.0.67%-3.26%-1.31%2.02%1.80%2.98%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
OMKAR PHARMACHEM LTD.-3.09%8.00%35.68%344.81%413.31%581.82%
Divi's Laboratories Ltd.0.83%89.86%56.44%484.44%1,625.50%9,907.51%

Performance & Financial Health Analysis: OMKAR PHARMACHEM LTD. vs Divi's Laboratories Ltd.

MetricOMKARPHDIVISLAB
Market Information
Market Cap i₹297.55M₹1.69T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i4253,443
90 Day Avg. Volume i1283,911
Last Close₹24.37₹6,576.50
52 Week Range₹24.37 - ₹29.74₹5,636.50 - ₹7,071.50
% from 52W High-18.06%-7.00%
All-Time High₹30.09 (May 26, 2025)₹7,071.50 (Jul 08, 2025)
% from All-Time High-19.01%-7.00%
Growth Metrics
Quarterly Revenue Growth-0.22%0.12%
Quarterly Earnings Growth-0.65%-0.01%
Financial Health
Profit Margin (TTM) i0.17%0.24%
Operating Margin (TTM) i0.38%0.30%
Return on Equity (TTM) i0.02%0.15%
Debt to Equity (MRQ) i0.000.58
Cash & Liquidity
Book Value per Share (MRQ)₹9.44₹580.95
Cash per Share (MRQ)₹0.06₹122.95
Operating Cash Flow (TTM) i₹2.44M₹19.67B
Levered Free Cash Flow (TTM) i₹2.01M₹21.91B
Dividends
Last 12-Month Dividend Yield iN/A0.91%
Last 12-Month Dividend iN/A₹60.00

Valuation & Enterprise Metrics Analysis: OMKAR PHARMACHEM LTD. vs Divi's Laboratories Ltd.

MetricOMKARPH (Apr 24, 2026)DIVISLAB (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i327.7867.11
Forward P/E iN/A53.75
PEG Ratio i-5.034.63
Price to Sales (TTM) i58.3416.18
Price to Book (MRQ) i3.1310.82
Market Capitalization
Market Capitalization i₹297.55M₹1.69T
Enterprise Value i₹296.42M₹1.64T
Enterprise Value Metrics
Enterprise to Revenue i58.1215.86
Enterprise to EBITDA i140.8848.63
Risk & Other Metrics
Beta i0.100.19
Book Value per Share (MRQ) i₹9.44₹580.95

Financial Statements Comparison: OMKAR PHARMACHEM LTD. vs Divi's Laboratories Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricOMKARPH (2025)DIVISLAB (2025)
Revenue/Sales i5.40M93.25B
Cost of Goods Sold i038.70B
COGS % of Revenue i0.0%41.5%
Gross Profit i5.40M54.55B
Gross Margin i100.0%58.5%
Research & Development iN/A270.00M
Operating Income (EBIT) i2.86M25.71B
Operating Margin i53.0%27.6%
EBITDA i2.93M33.19B
EBITDA Margin i54.3%35.6%
Pre-Tax Income i2.70M29.16B
Pre-Tax Income % of Revenue i50.0%31.3%
Income Tax i691,0007.25B
Income Tax % of Revenue i12.8%7.8%
Net Income (Profit) i2.01M21.91B
Profit Margin i37.2%23.5%

Balance Sheet & Liquidity Metrics

MetricOMKARPH (2025)DIVISLAB (2025)
Cash & Equivalents i1.09M4.15B
Total Current Assets i2.65M100.81B
Total Current Assets % of Revenue i49.1%108.1%
Total Current Liabilities i1.70M14.52B
Total Current Liabilities % of Revenue i31.4%15.6%
Long-Term Debt i020.00M
Long-Term Debt % of Revenue i0.0%0.0%
Total Shareholders Equity i94.34M149.69B
Retained Earnings i-6.50M134.00B
Retained Earnings % of Revenue i-120.4%143.7%
Property, Plant & Equipment i183,0003.19B

Cash Flow Statement Comparison

MetricOMKARPH (2025)DIVISLAB (2025)
Operating Cash Flow i2.44M19.67B
Operating Cash Flow % of Revenue i45.2%21.1%
Capital Expenditures i-40,000-14.38B
Free Cash Flow i2.40M2.15B
FCF Margin i44.4%2.3%
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricOMKARPHDIVISLAB
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i10.08M265.47M
Float Shares i4.97M117.72M
% Held by Insiders i51.14%52.04%
% Held by Institutions i0.00%28.65%
% Held by Public i48.86%19.31%

Dividend Analysis & Yield Comparison: OMKAR PHARMACHEM LTD. vs Divi's Laboratories Ltd.

MetricOMKARPHDIVISLAB
Last 12-Month Dividend iN/A₹60.00
Last 12-Month Dividend Yield iN/A0.91%
3-Year Avg Annual Dividend iN/A₹50.00
3-Year Avg Dividend Yield iN/A0.70%
3-Year Total Dividends iN/A₹150.00
Ex-Dividend DateN/AJul 25, 2025